Presentation THT 2025 Trend and Impact of Right Heart Catheterization on Outcomes in Cardiogenic Shock Presenter: Qianlan Xi February 12, 2025
Presentation THT Abstracts 2025 Trend and Impact of Right Heart Catheterization on Outcomes in Cardiogenic Shock Presenter: Qianlan Xi February 11, 2025
News Conference News AHA 2024 Novel AI-Based, Noninvasive Sensor Can Accurately Measure PCWP in HFrEF Yael L. Maxwell November 25, 2024
News Daily News Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF Michael O'Riordan July 26, 2024
News Conference News ACC 2024 Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF Michael O'Riordan April 06, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2024 Shelley Wood February 01, 2024
News Daily News Experts Warn of Looming Private Equity Interest in Cardiology Care Michael O'Riordan January 15, 2024
News Conference News HFSA 2023 REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation Todd Neale October 11, 2023
News Daily News Monitoring PA Pressures With CardioMEMS May Help LVAD Patients Todd Neale April 27, 2023
News Conference News TCT 2022 Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test Shelley Wood September 18, 2022
News Conference News ESC 2022 New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment Shelley Wood September 01, 2022
News Daily News FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor Shelley Wood February 22, 2022
Presentation THT 2022 Right heart catheterization + Exercise testing – best practices for treatment selection in patients with PH due to Left Heart Disease Presenter: Ryan Tedford February 01, 2022
News Conference News HFSA 2021 PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF Todd Neale September 13, 2021
News Conference News ESC 2021 GUIDE-HF: Pulmonary Artery Sensor May Help in Mild HF, but COVID-19 Muddies Water Shelley Wood August 27, 2021
News Daily News Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF Michael O'Riordan April 15, 2021